Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HEI9
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 240 | 242 | PF00675 | 0.488 |
CLV_NRD_NRD_1 | 246 | 248 | PF00675 | 0.574 |
CLV_NRD_NRD_1 | 26 | 28 | PF00675 | 0.559 |
CLV_NRD_NRD_1 | 58 | 60 | PF00675 | 0.477 |
CLV_PCSK_KEX2_1 | 185 | 187 | PF00082 | 0.455 |
CLV_PCSK_KEX2_1 | 240 | 242 | PF00082 | 0.476 |
CLV_PCSK_KEX2_1 | 246 | 248 | PF00082 | 0.392 |
CLV_PCSK_KEX2_1 | 26 | 28 | PF00082 | 0.560 |
CLV_PCSK_KEX2_1 | 58 | 60 | PF00082 | 0.477 |
CLV_PCSK_PC1ET2_1 | 185 | 187 | PF00082 | 0.479 |
CLV_PCSK_PC1ET2_1 | 58 | 60 | PF00082 | 0.477 |
CLV_PCSK_SKI1_1 | 182 | 186 | PF00082 | 0.492 |
CLV_PCSK_SKI1_1 | 192 | 196 | PF00082 | 0.511 |
CLV_PCSK_SKI1_1 | 264 | 268 | PF00082 | 0.538 |
CLV_PCSK_SKI1_1 | 59 | 63 | PF00082 | 0.665 |
DEG_APCC_DBOX_1 | 58 | 66 | PF00400 | 0.403 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.733 |
DOC_MAPK_DCC_7 | 58 | 67 | PF00069 | 0.396 |
DOC_MAPK_gen_1 | 58 | 67 | PF00069 | 0.396 |
DOC_MAPK_MEF2A_6 | 60 | 69 | PF00069 | 0.493 |
DOC_MAPK_RevD_3 | 226 | 241 | PF00069 | 0.598 |
DOC_PP4_FxxP_1 | 166 | 169 | PF00568 | 0.445 |
DOC_PP4_FxxP_1 | 248 | 251 | PF00568 | 0.503 |
DOC_PP4_FxxP_1 | 9 | 12 | PF00568 | 0.726 |
DOC_USP7_MATH_1 | 76 | 80 | PF00917 | 0.429 |
DOC_USP7_UBL2_3 | 188 | 192 | PF12436 | 0.622 |
DOC_USP7_UBL2_3 | 221 | 225 | PF12436 | 0.481 |
DOC_WW_Pin1_4 | 124 | 129 | PF00397 | 0.561 |
LIG_14-3-3_CanoR_1 | 240 | 244 | PF00244 | 0.494 |
LIG_14-3-3_CanoR_1 | 262 | 267 | PF00244 | 0.599 |
LIG_14-3-3_CanoR_1 | 75 | 81 | PF00244 | 0.443 |
LIG_BRCT_BRCA1_1 | 112 | 116 | PF00533 | 0.413 |
LIG_deltaCOP1_diTrp_1 | 259 | 267 | PF00928 | 0.522 |
LIG_EH1_1 | 37 | 45 | PF00400 | 0.572 |
LIG_EVH1_2 | 168 | 172 | PF00568 | 0.487 |
LIG_FHA_1 | 125 | 131 | PF00498 | 0.535 |
LIG_FHA_1 | 142 | 148 | PF00498 | 0.324 |
LIG_FHA_1 | 69 | 75 | PF00498 | 0.445 |
LIG_FHA_1 | 91 | 97 | PF00498 | 0.541 |
LIG_FHA_2 | 160 | 166 | PF00498 | 0.336 |
LIG_LIR_Apic_2 | 163 | 169 | PF02991 | 0.449 |
LIG_LIR_Apic_2 | 6 | 12 | PF02991 | 0.694 |
LIG_LIR_Gen_1 | 113 | 124 | PF02991 | 0.408 |
LIG_LIR_Gen_1 | 174 | 184 | PF02991 | 0.500 |
LIG_LIR_Nem_3 | 113 | 119 | PF02991 | 0.392 |
LIG_LIR_Nem_3 | 174 | 180 | PF02991 | 0.450 |
LIG_LIR_Nem_3 | 242 | 248 | PF02991 | 0.530 |
LIG_PCNA_PIPBox_1 | 227 | 236 | PF02747 | 0.495 |
LIG_PCNA_yPIPBox_3 | 221 | 234 | PF02747 | 0.468 |
LIG_PDZ_Class_3 | 277 | 282 | PF00595 | 0.556 |
LIG_Pex14_2 | 244 | 248 | PF04695 | 0.493 |
LIG_SH2_NCK_1 | 177 | 181 | PF00017 | 0.562 |
LIG_SH2_STAT3 | 233 | 236 | PF00017 | 0.503 |
LIG_SH2_STAT3 | 273 | 276 | PF00017 | 0.648 |
LIG_SH2_STAT5 | 203 | 206 | PF00017 | 0.431 |
LIG_SH2_STAT5 | 223 | 226 | PF00017 | 0.487 |
LIG_SH2_STAT5 | 89 | 92 | PF00017 | 0.417 |
LIG_SH3_3 | 145 | 151 | PF00018 | 0.442 |
LIG_SH3_3 | 269 | 275 | PF00018 | 0.647 |
LIG_SUMO_SIM_anti_2 | 93 | 100 | PF11976 | 0.383 |
LIG_SUMO_SIM_par_1 | 210 | 217 | PF11976 | 0.456 |
MOD_CDK_SPxxK_3 | 124 | 131 | PF00069 | 0.567 |
MOD_CK2_1 | 76 | 82 | PF00069 | 0.406 |
MOD_GlcNHglycan | 122 | 125 | PF01048 | 0.359 |
MOD_GlcNHglycan | 13 | 16 | PF01048 | 0.655 |
MOD_GlcNHglycan | 156 | 159 | PF01048 | 0.414 |
MOD_GlcNHglycan | 204 | 207 | PF01048 | 0.430 |
MOD_GlcNHglycan | 46 | 49 | PF01048 | 0.631 |
MOD_GSK3_1 | 120 | 127 | PF00069 | 0.536 |
MOD_GSK3_1 | 235 | 242 | PF00069 | 0.528 |
MOD_GSK3_1 | 49 | 56 | PF00069 | 0.642 |
MOD_N-GLC_1 | 104 | 109 | PF02516 | 0.458 |
MOD_N-GLC_2 | 104 | 106 | PF02516 | 0.505 |
MOD_NEK2_1 | 202 | 207 | PF00069 | 0.419 |
MOD_NEK2_1 | 239 | 244 | PF00069 | 0.599 |
MOD_NEK2_1 | 44 | 49 | PF00069 | 0.669 |
MOD_PK_1 | 262 | 268 | PF00069 | 0.575 |
MOD_PKA_2 | 239 | 245 | PF00069 | 0.529 |
MOD_Plk_4 | 39 | 45 | PF00069 | 0.579 |
MOD_ProDKin_1 | 124 | 130 | PF00069 | 0.552 |
MOD_SUMO_for_1 | 187 | 190 | PF00179 | 0.609 |
MOD_SUMO_rev_2 | 163 | 169 | PF00179 | 0.429 |
MOD_SUMO_rev_2 | 181 | 187 | PF00179 | 0.566 |
TRG_ENDOCYTIC_2 | 177 | 180 | PF00928 | 0.448 |
TRG_ENDOCYTIC_2 | 245 | 248 | PF00928 | 0.568 |
TRG_ER_diArg_1 | 239 | 241 | PF00400 | 0.499 |
TRG_ER_diArg_1 | 245 | 247 | PF00400 | 0.384 |
TRG_ER_diArg_1 | 261 | 264 | PF00400 | 0.622 |
TRG_NLS_MonoExtC_3 | 184 | 190 | PF00514 | 0.602 |
TRG_NLS_MonoExtN_4 | 182 | 189 | PF00514 | 0.564 |
TRG_Pf-PMV_PEXEL_1 | 17 | 21 | PF00026 | 0.496 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P8J2 | Leptomonas seymouri | 81% | 100% |
A0A0S4ITS5 | Bodo saltans | 58% | 100% |
A0A1X0NY80 | Trypanosomatidae | 68% | 100% |
A0A3S7WZA4 | Leishmania donovani | 88% | 100% |
A4I1M9 | Leishmania infantum | 88% | 100% |
C9ZK74 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 65% | 99% |
E9AXR3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 87% | 100% |
Q4Q9Q8 | Leishmania major | 89% | 100% |
V5BHW7 | Trypanosoma cruzi | 67% | 100% |